Can Mitochondrial Biogenesis be Therapeutically Targeted?
Yes, promoting mitochondrial biogenesis is considered a potential therapeutic strategy for various diseases. Pharmacological agents that activate PGC-1α, AMPK, or SIRT1 are being investigated for their ability to enhance mitochondrial biogenesis. Additionally, lifestyle interventions such as exercise and dietary modifications are known to stimulate mitochondrial biogenesis.